List of works - Paolo Marchetti

Endocrine side effects induced by immune checkpoint inhibitors.

scientific article published on 07 March 2013

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

article

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

scientific article

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

scientific article

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

scientific article published on 25 September 2013

Use of strong opioids in advanced cancer pain: a randomized trial.

scientific article

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

scientific article

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

scientific article

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

scientific article published in May 2006

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

scientific article

Physical exercise and quality of life in breast cancer survivors

scientific article

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

scientific article published on 04 April 2014

Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.

scientific article published in March 2002

Metronomic chemotherapy for cancer treatment: a decade of clinical studies

scientific article published on 09 March 2013

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

scientific article

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.

scientific article

Weekly administration of paclitaxel: theoretical and clinical basis

scientific article

Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism.

scientific article published on 21 October 2008

Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational study.

scientific article published on 20 March 2014

Triple positive breast cancer: a distinct subtype?

scientific article published on 19 December 2014

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

scientific article published on 11 April 2016

Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.

scientific article

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

scientific article published on 27 February 2019

Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab

scientific article published on 27 December 2011

Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer

scientific article published on August 13, 2013

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer

scientific article

Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.

scientific article

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

scientific article

Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group

scientific article published on 05 October 2015

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study

scientific article published on 10 August 2017

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

scientific article published on 11 March 2014

Overcoming cultural barriers to giving bad news: feasibility of training to promote truth-telling to cancer patients

scientific article published in January 2009

Tumors of ampulla of Vater: A case series and review of chemotherapy options

scientific article published on March 15, 2012

Chemotherapy for the biliary tract cancers: moving toward improved survival time

scientific article published on September 2012

Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations

scientific article published on 01 November 2004

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

scientific article

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

scientific article published on 2 May 2015

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

scientific article published in November 2017

Premetastatic niche: ready for new therapeutic interventions?

scientific article published on 23 March 2012

Brain Metastases: Surgical Treatment and Overall Survival

scientific article published on 22 September 2016

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

scientific article published on 13 November 2007

Current challenges in HER2-positive breast cancer.

scientific article

Treatment-related side effects and quality of life in cancer patients.

scientific article published on 21 January 2012

Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy

scientific article published on 31 March 2014

Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.

scientific article published in March 2006

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models

scientific article published on 01 June 2006

Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings

scientific article published on March 2015

Nutritional support for cancer patients: still a neglected right?

scientific article published on 14 July 2017

An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer

scientific article published on 01 May 2004

Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism

scientific article published on 31 March 2006

List of works by Paolo Marchetti

Endocrine side effects induced by immune checkpoint inhibitors.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

Use of strong opioids in advanced cancer pain: a randomized trial.

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

Physical exercise and quality of life in breast cancer survivors

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.

Metronomic chemotherapy for cancer treatment: a decade of clinical studies

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.

Weekly administration of paclitaxel: theoretical and clinical basis

Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism.

Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational study.

Triple positive breast cancer: a distinct subtype?

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab

Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer

Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

Overcoming cultural barriers to giving bad news: feasibility of training to promote truth-telling to cancer patients

Tumors of ampulla of Vater: A case series and review of chemotherapy options

Chemotherapy for the biliary tract cancers: moving toward improved survival time

Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Premetastatic niche: ready for new therapeutic interventions?

Brain Metastases: Surgical Treatment and Overall Survival

Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells.

Current challenges in HER2-positive breast cancer.

Treatment-related side effects and quality of life in cancer patients.

Cytokines, fatigue, and cutaneous erythema in early stage breast cancer patients receiving adjuvant radiation therapy

Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models

Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings

Nutritional support for cancer patients: still a neglected right?

An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer

Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism